Jim Cramer advises selling Hims & Hers Health Inc. stock after a 35% decline

From Yahoo Finance: 2025-06-27 03:27:00

Hims & Hers Health, Inc. (NYSE:HIMS) is one of the 14 stocks Jim Cramer recently shared insights on, emphasizing the importance of discipline in trading. The online healthcare company saw a 35% decline after almost tripling in two months, prompting Cramer to urge investors to sell and secure gains.

Hims & Hers Health (NYSE:HIMS) operates a telehealth platform offering prescription and non-prescription health products. Their range includes medication, skin care, sexual health, hair care, and wellness items, with ongoing support from licensed healthcare professionals.

While HIMS shows potential as an investment, some AI stocks offer greater upside potential with lower downside risk. For an undervalued AI stock poised to benefit from Trump-era tariffs and the onshoring trend, check out a free report on the best short-term AI stock.

Disclosure: None.



Read more at Yahoo Finance: “You Gotta Generate Some Discipline Here”